Wellness products company Nature’s Sunshine (NASDAQ:NATR) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 8.5% year on year to $122.9 mil...
Heating and cooling solutions company AAON (NASDAQ:AAON) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 54.3% year on year ...
Atmus Filtration Technologies’ first quarter was marked by a year-on-year sales increase driven largely by its acquisition of Cook Filter and modest price ga...
Laser company nLIGHT (NASDAQ:LASR) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 55.2% year on year to $80.18 million. On ...
Church & Dwight’s first quarter results saw sales remain flat year over year, but organic revenue growth outpaced category averages, driven by volume rather ...
Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 1.2% year on y...
Ares Management’s first quarter saw strong revenue growth, with management attributing performance to robust institutional fundraising and broad-based produc...
Animal health company Zoetis (NYSE:ZTS) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 2.9% year on year to $2.26 billion. The co...
Medication company Viatris (NASDAQ:VTRS) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 8.1% year on year to $3.52 bill...
Colgate-Palmolive began 2026 with positive momentum, as Q1 results exceeded Wall Street’s revenue and non-GAAP profit expectations. Management credited impro...
Private equity firm Carlyle Group (NASDAQ:CG) missed Wall Street’s revenue expectations in Q1 CY2026, with sales falling 75.7% year on year to $254 million. ...
Chip designer Allegro MicroSystems (NASDAQ:ALGM) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 26.1% year on year to $243.2 million. Gu...
Behavioral health company LifeStance Health (NASDAQ:LFST) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 21.2% year on...
Payment processing company Shift4 Payments (NYSE:FOUR) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 32.1% year on year to $1.12 billio...
Electronic bond trading platform MarketAxess (NASDAQ:MKTX) announced better-than-expected revenue in Q1 CY2026, with sales up 11.9% year on year to $233.4 mi...
Biotech company 10x Genomics (NASDAQ:TXG) announced better-than-expected revenue in Q1 CY2026, but sales fell by 2.6% year on year to $150.8 million. The com...
BrightSpring Health Services delivered results in Q1 that surpassed Wall Street’s expectations, with the market responding positively to broad-based growth a...
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 4.4% year on year to...
Energy drink company Celsius (NASDAQ:CELH) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 138% year on year to $782.6 mi...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 5.5% year on ...
Medical technology company Teleflex (NYSE:TFX) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 32.3% year on year to $5...
Alternative fuel provider Clean Energy Fuels (NASDAQ:CLNE) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 13.3% year o...
Doughnut chain Krispy Kreme (NASDAQ:DNUT) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 2.2% year on year to $367...
Moderna’s first quarter was marked by a sharp increase in revenue, driven by the fulfillment of large international contracts, particularly through a strateg...
Wendy's (WEN) to release Q1 earnings on May 8. Analysts predict 10 cents/share, down from 20 cents last year. Stock rose 0.6% on Thursday. See latest analyst ratings and target prices.
